LLY: Eli Lilly and Company Stock Live Price Graph
About the company
Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This encompasses various insulin formulations like Basaglar, the Humalog family (e.g., Mix 75/25, U-100, U-200, Mix 50/50), insulin lispro products (including protamine and mix 75/25), and the Humulin line (e.g., 70/30, N, R, U-500). Furthermore, Eli Lilly provides specialized treatments for type 2 diabetes, such as Jardiance, Trajenta, and Trulicity. In oncology, Eli Lilly offers a robust portfolio targeting various cancers. These include Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza, indicated for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal and various head and neck cancers; Retevmo, used in metastatic NSCLC, medullary thyroid, and other thyroid cancers; Tyvyt for relapsed or refractory classic Hodgkin's lymphoma and non-squamous NSCLC; and Verzenio, prescribed for HR+, HER2- metastatic breast cancer, node-positive, and early breast cancer. For autoimmune and inflammatory conditions, the company markets Olumiant for rheumatoid arthritis, and Taltz, which addresses plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Addressing neurological and pain management needs, Eli Lilly provides Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain. Emgality is available for migraine prevention and episodic cluster headaches, while Zyprexa treats schizophrenia, bipolar I disorder, and aids in bipolar maintenance. Other significant products include Bamlanivimab and etesevimab, along with Bebtelovimab, both developed for COVID-19. Cialis is offered for erectile dysfunction and benign prostatic hyperplasia, and Forteo is available for osteoporosis. Eli Lilly actively engages in strategic collaborations with numerous partners, including Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Established in 1876, Eli Lilly and Company maintains its corporate headquarters in Indianapolis, Indiana.
Company profile
Market News & Analysis
Target Price
No analyst target price data is available for this instrument.
Dividend History
Cash dividends
| Payment | Gross / share | Net / share | Yield | Per 1,000 TRY |
|---|---|---|---|---|
| - | $1.73 | $1.73 | 0.64% | - |
What Is LLY? Live LLY Prices and Analysis
LLY, or Eli Lilly and Company, is a global pharmaceutical company known for its commitment to innovation in healthcare. Founded in 1876, the company has grown to become a leader in developing a wide range of medications, particularly in the fields of diabetes, oncology, and immunology. Investors closely monitor LLY due to its significant impact on the healthcare sector and its potential for long-term growth.
As a publicly traded company on the New York Stock Exchange, LLY attracts a diverse range of investors seeking exposure to the pharmaceutical industry. Its performance can greatly influence market sentiment, making it a vital stock to watch for those interested in healthcare investments.
Market Context
The stock market for pharmaceutical companies like LLY is influenced by various factors including international trading dynamics, regulatory changes, and pricing currencies. The volatility within the sector can be significant, especially in response to new drug approvals, patent expirations, and competitive pressures from other companies. Investors often keep a close eye on global healthcare trends and economic indicators that may affect LLY's performance.
Why Do LLY Prices Rise or Fall?
LLY's stock price can fluctuate based on several key factors, which include:
- Drug Approval and Regulatory News: Positive outcomes from clinical trials or FDA approvals can lead to stock price surges.
- Earnings Reports: Quarterly earnings that exceed or fall short of analyst expectations can significantly impact LLY's market valuation.
- Market Sentiment: Investor perception of the pharmaceutical industry, influenced by news and trends, can affect LLY's stock price.
- Competitive Landscape: New entrants or advancements by competitors can pose risks to LLY's market share.
- Global Health Trends: Changes in healthcare policies, especially in major markets, can influence LLY's business environment.
- Dividend Announcements: Changes in dividend payouts can attract or deter investors, impacting stock prices.
- Economic Indicators: Broader economic conditions, such as changes in interest rates or unemployment rates, can affect healthcare spending.
- Merger and Acquisition Activity: Potential mergers or acquisitions can create speculation and volatility around LLY’s stock.
Overall, understanding these factors can provide investors with insights into the potential movements of LLY’s stock price.
Why Is Live LLY Price Tracking Important?
Tracking LLY's live stock price is crucial for investors for several reasons:
- Real-Time Data: Access to current price information allows investors to make informed decisions quickly.
- Market Sentiment: Live tracking can reflect immediate investor sentiment and reactions to news.
- Technical Analysis: Investors can use live price data for technical analysis to identify trends and potential entry or exit points.
- Portfolio Management: Monitoring LLY's price helps investors manage their portfolios effectively, adjusting their positions as needed.
- Investment Strategy: Real-time tracking aids in executing investment strategies based on market movements.
What Should You Consider When Trading / Investing in LLY?
Investing in LLY, like any stock, involves certain risks and considerations:
- Regulatory Risks: The pharmaceutical industry is heavily regulated, and changes can impact LLY's operations.
- Market Volatility: The stock can experience significant price swings based on news and earnings releases.
- Dependence on Drug Portfolio: LLY's success is closely tied to its drug portfolio and the success of its pipeline products.
- Economic Sensitivity: Broader economic conditions can influence healthcare spending and LLY's revenue.
- Global Competition: The competitive landscape can affect LLY’s market share and pricing power.
What Can You Find on the Investvio LLY Page?
- Live Price Updates: Stay informed about LLY's current stock price.
- Interactive Charts: Analyze price movements and trends over time.
- Technical Analysis: Access expert insights and analysis to guide your trading decisions.
- Latest News: Get updates on company announcements, earnings reports, and market developments.
- Dividend Information: Find details on LLY's dividend history and upcoming payments.
By utilizing the resources available on the Investvio LLY page, investors can enhance their understanding of the stock and make more informed investment decisions.